Oppenheimer analyst Kristen Owen maintains $Ingredion (INGR.US)$ with a buy rating, and adjusts the target price from $138 to $178.
According to TipRanks data, the analyst has a success rate of 53.0% and a total average return of 5.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Ingredion (INGR.US)$'s main analysts recently are as follows:
The company has reported yet another robust quarter of profits, bolstered by its cost-saving initiatives and restructuring of business segments. This has propelled earnings as the firm capitalizes on strong demand and increased volumes which enhances cost absorption.
The company surpassed anticipated performance with its highest recorded Q3 EBIT and an increased guidance, suggesting a robust Q4 outcome. It is expected that the company's performance will continue to be solid through 2025, underpinned by effective operational management, favorable contract renewals, a supportive industry backdrop, and an increasing ability to undertake high-yield investments.
The company exhibited a robust third quarter and heightened its full-year 2024 forecasts above consensus expectations. The firm acknowledges that results were bolstered by escalating volume growth in Texture & Healthful Solutions. This growth, along with the advantages derived from the company's cost competitiveness efforts and effective price-to-cost management, contributed to the earnings per share surpassing estimates by 45 cents.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
奧本海默控股分析師Kristen Owen維持$宜瑞安 (INGR.US)$買入評級，並將目標價從138美元上調至178美元。
根據TipRanks數據顯示，該分析師近一年總勝率為53.0%，總平均回報率為5.5%。
此外，綜合報道，$宜瑞安 (INGR.US)$近期主要分析師觀點如下：
該公司公佈了又一個強勁的季度利潤，這得益於其成本節約舉措和業務部門重組。這推動了收益，因爲該公司利用了強勁的需求和增加的銷量，從而提高了成本吸收。
該公司以創紀錄的第三季度息稅前利潤和更高的預期業績超出了預期，這表明第四季度業績強勁。預計到2025年，該公司的業績將繼續保持穩健，這要歸因於有效的運營管理、有利的合同續約、支持性的行業背景以及進行高收益投資的能力的提高。
該公司第三季度表現強勁，並將2024年全年預測提高至超出市場普遍預期。該公司承認，Texture & Healthful Solutions的銷量增長推動了業績。這種增長，加上公司努力提高成本競爭力和有效的成本管理所帶來的優勢，使每股收益比預期高出45美分。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
